v3.26.1
Stock-Based Incentive Compensation Plans
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Stock-Based Incentive Compensation Plans Stock-Based Incentive Compensation Plans
Stock Options
The table below summarizes the stock option activity for the six months ended June 30, 2026:
Number of
Shares
Weighted-
Average
Exercise
Price
Weighted-Average Contractual Remaining Life (Years)Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2025803,172 $11.99 
Exercised
(106,879)$4.42 
Canceled and forfeited(2,765)$10.80 
Outstanding as of June 30, 2026693,528 $13.16 1.75$3,847 
Options vested and exercisable, June 30, 2026
693,528 $13.16 1.75$3,847 
Options vested and expected to vest, June 30, 2026
693,528 $13.16 1.75$3,847 
As of June 30, 2026, there is no unrecognized compensation cost related to stock options.
There were no stock options granted during the three and six months ended June 30, 2026 and 2025.
Restricted Stock Units (“RSUs”)
RSUs are share awards that entitle the holder to receive freely tradable shares of the Company’s common stock upon vesting. RSUs generally vest over one to four years based upon continued services and are settled at vesting in shares of the Company's common stock. Certain RSUs vest based upon continued services and the achievement of financial milestones. The grant date fair value of the RSUs is equal to the closing price of the Company’s common stock on the grant date.
The Company granted performance-based restricted stock unit awards subject to market and service vesting conditions to certain executive officers under SI-BONE's 2018 Equity Incentive Plan (“PSUs”). The shares subject to PSUs vest over a three-year performance period. The actual number of PSUs that will vest in each measurement period will be determined by the Compensation Committee based on the Company’s total shareholder return (“TSR”) relative to the TSR of the Median Peer Companies (as defined in the award agreement). The grant date fair value of each stock award with a market condition was determined using the Monte Carlo valuation model. The table below summarizes the assumptions used to estimate the grant date fair value of the PSUs granted:
Six Months Ended June 30,
2026
2025
Expected volatility of common stock48.0%to51.0%49.0%to57.0%
Expected volatility of peer companies31.0%to110.0%30.0%to126.0%
Correlation coefficient of peer companies(0.08)to1.000.05to1.00
Risk-free interest rate3.3%to3.4%4.1%to4.2%
Dividend yield—%to1.0%—%to1.0%
The table below summarizes RSU and PSU activity for the six months ended June 30, 2026:
RSUsPSUs
Number of SharesWeighted Average Grant Date Fair ValueNumber of SharesWeighted Average Grant Date Fair Value
Outstanding as of December 31, 20251,916,581$17.30785,457$16.17
Granted1,234,63915.35178,86013.23
Vested(577,401)17.47(267,006)14.44
Canceled and forfeited(95,844)16.61(1,731)11.08
Outstanding as of June 30, 20262,477,97516.31695,58016.09
Employee Stock Purchase Plan
The Company’s 2018 Employee Stock Purchase Plan (the “ESPP”) allows eligible employees to purchase shares of the Company's common stock through payroll deductions at the price equal to 85% of the lesser of the fair market value of the stock as of the first date or the ending date of each six month offering period. The offering period generally commences in May and November. On March 26, 2020, the Company's Compensation Committee approved the amendment of the terms of future offerings under the ESPP which, among other things, increased the maximum number of shares that may be purchased on any single purchase date, provided for automatic enrollment in a new offering.
The fair value of the ESPP shares is estimated using the Black-Scholes option pricing model, which is being amortized over the requisite service period. As of June 30, 2026 and December 31, 2025, total accumulated ESPP related employee payroll deductions amounted to $0.2 million and $0.3 million, respectively, which were included within accrued compensation and related expenses in the condensed consolidated balance sheets.
Stock-Based Compensation
The table below presents the detail of stock-based compensation expense amounts included in the condensed consolidated statements of operations:
Three Months Ended
June 30,
Six Months Ended
June 30,
2026202520262025
(in thousands)
Cost of goods sold
$180 $175 $311 $335 
Sales and marketing
2,001 2,466 4,314 5,089 
Research and development
709 833 1,397 1,667 
General and administrative
3,089 3,184 5,982 6,230 
$5,979 $6,658 $12,004 $13,321 
Warrants
The table below summarizes common stock warrants activity for the six months ended June 30, 2026:
DateOutstanding Balance atPrice per ShareWarrants IssuedWarrant ExercisedWarrant ExpiredOutstanding Balance at
IssuanceExpirationDecember 31, 2025June 30, 2026
3/1/20173/1/20271,388 $5.94 1,388 
12/22/201612/22/20269,712 $10.03 9,712 
11,100 11,100